[B! ã‚¦ã‚¤ãƒ«ã‚¹][COVID-19] ss56235ã®ãƒ

ss56235 id:ss56235

ã‚¦ã‚¤ãƒ«ã‚¹ã¨COVID-19ã«é–¢ã™ã‚‹ss56235ã®ãƒ–ãƒƒã‚¯ãƒžãƒ¼ã‚¯ (7)

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

${{author_name}}$
{{author_name}}{{created}}
{{ #comment }}{{ comment }}{{ /comment }}
- {{ label }}

${{author_name}}$

{{{comment_expanded}}}

{{label}}

{{#is_bookmark}}ãƒªã‚¹ãƒˆ{{/is_bookmark}}{{^is_bookmark}}ãƒªãƒ³ã‚¯{{/is_bookmark}}

æ–°åž‹ã‚³ãƒãƒŠã€€ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã®ç™»å ´ã«ã‚ˆã£ã¦ã€Œã‚³ãƒãƒŠã¯é¢¨é‚ªã€ã«è¿‘ã¥ã„ãŸã¨è¨€ãˆã‚‹ã®ã‹ï¼Ÿï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã¯å¼±æ¯’åŒ–ã—ã¦ãŠã‚Šã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶ã‚„é¢¨é‚ªã«è¿‘ã¥ã„ã¦ã„ã‚‹ã€ã¨ã„ã†æ„è¦‹ã‚’ã‚ˆãç›®ã«ã—ã¾ã™ãŒã€ã“ã‚Œã¯æœ¬å½“ã§ã—ã‚‡ã†ã‹ï¼Ÿ ã•ã‚‰ã«ã€Œã“ã®ã¾ã¾ã‚³ãƒãƒŠã¯å¼±æ¯’åŒ–ã—ã¦ã„ã£ã¦é¢¨é‚ªã«ãªã£ã¦ã„ãã€ã¨ã„ã†è©±ã‚‚ã‚ˆãèžãã¾ã™ã€‚ã“ã‚Œã‚‚ã©ã“ã¾ã§æ ¹æ‹ ã®ã‚ã‚‹è©±ãªã®ã§ã—ã‚‡ã†ã‹ã€‚ ç¬¬6æ³¢ã®1æ—¥å½“ãŸã‚Šã®æ»äº¡è€…æ•°ã¯éŽåŽ»æœ€å¤§æ—¥æœ¬ã«ãŠã‘ã‚‹æ–°åž‹ã‚³ãƒãƒŠæ»äº¡è€…æ•°ã®æŽ¨ç§»ï¼ˆåŽšç”ŸåŠ´åƒçœ ãƒ‡ãƒ¼ã‚¿ã‹ã‚‰ã‚ã‹ã‚‹ï¼æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡æƒ…å ±ï¼ã®ãƒ‡ãƒ¼ã‚¿ã‚’å…ƒã«ç†è€…ä½œæˆï¼‰ ã¾ãšã€ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã¯å¼±æ¯’åŒ–ã—ã¦ã„ã‚‹ã¨ã„ã†ã“ã¨ãŒå¼·èª¿ã•ã‚Œã™ãŽã¦ã„ã¾ã™ãŒã€ã€Œæ–°åž‹ã‚³ãƒãƒŠ ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã®æ„ŸæŸ“è€…ãŒé‡ç—‡åŒ–ã—ã«ãã„ã®ã¯ãªãœã‹ï¼Ÿã€ã§ã‚‚æ›¸ã„ãŸé€šã‚Šé‡ç—‡åŒ–ã™ã‚‹äººãŒå°‘ãªã„ã®ã¯æ„ŸæŸ“è€…ã®å¤šããŒãƒ¯ã‚¯ãƒãƒ³æŽ¥ç¨®è€…ã€éŽåŽ»ã«æ„ŸæŸ“ã—ãŸäººãŒæ„ŸæŸ“ã—ã¦ã„ã‚‹ã‹ã‚‰ã§ã‚ã‚Šã€ã‚ªãƒŸã‚¯ãƒãƒ³æ ªã®ç—…åŽŸæ€§ãã®ã‚‚ã®ã¯æ¦æ¼¢å¸‚ã§æœ€åˆã«åºƒãŒã£ãŸæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¨åŒç‰ãã‚‰ã„ã¨è€ƒãˆã‚‰ã‚Œã¦ã„ã¾ã™ã€‚ ãƒ¯ã‚¯ãƒãƒ³æœªæŽ¥ç¨®è€…ã€ãã—ã¦2å›žç›®ã®ãƒ¯ã‚¯ãƒãƒ³æŽ¥ç¨®ã‹
ss56235 2022/02/20
COVID-19

ã‚³ãƒãƒŠ

ã‚¦ã‚¤ãƒ«ã‚¹

ã‚¤ãƒ³ãƒ•ãƒ«ã‚¨ãƒ³ã‚¶
ãƒªãƒ³ã‚¯
ã‚¦ã‚¤ãƒ«ã‚¹ã®æ„ŸæŸ“åŠ›ã‚’é«˜ã‚ã€æ—¥æœ¬äººã«é«˜é »åº¦ãªç´°èƒžæ€§å…ç–«å¿œç”ã‹ã‚‰å…ã‚Œã‚‹SARS-CoV-2å¤‰ç•°ã®ç™ºè¦‹ | å›½ç«‹ç ”ç©¶é–‹ç™ºæ³•äººæ—¥æœ¬åŒ»ç™‚ç ”ç©¶é–‹ç™ºæ©Ÿæ§‹
ä½è—¤ã€€ä½³ï¼ˆæ±äº¬å¤§å¦åŒ»ç§‘å¦ç ”ç©¶æ‰€ã€€é™„å±žæ„ŸæŸ“ç—‡å›½éš›ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€€ã‚·ã‚¹ãƒ†ãƒ ã‚¦ã‚¤ãƒ«ã‚¹å¦åˆ†é‡Žã€€å‡†æ•™æŽˆï¼‰ â€»ç ”ç©¶ã‚³ãƒ³ã‚½ãƒ¼ã‚·ã‚¢ãƒ ã€ŒThe Genotype to Phenotype Japanï¼ˆG2P-Japanï¼‰ã€ï¼ˆæ³¨1ï¼‰ãƒ¡ãƒ³ãƒãƒ¼ ä½è—¤ã€€ä½³ï¼ˆæ±äº¬å¤§å¦åŒ»ç§‘å¦ç ”ç©¶æ‰€ã€€é™„å±žæ„ŸæŸ“ç—‡å›½éš›ç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€€ã‚·ã‚¹ãƒ†ãƒ ã‚¦ã‚¤ãƒ«ã‚¹å¦åˆ†é‡Žã€€å‡†æ•™æŽˆï¼‰ æœ¬åœ’ã€€åƒå°‹ï¼ˆç†Šæœ¬å¤§å¦ãƒ’ãƒˆãƒ¬ãƒˆãƒã‚¦ã‚¤ãƒ«ã‚¹å¦å…±åŒç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€€æ„ŸæŸ“äºˆé˜²éƒ¨é–€æ„ŸæŸ“å…ç–«å¦åˆ†é‡Žã€€è¬›å¸«ï¼‰ ä¸å·ã€€è‰ï¼ˆæ±æµ·å¤§å¦ã€€åŒ»å¦éƒ¨åŒ»å¦ç§‘ã€€åŸºç¤ŽåŒ»å¦ç³»åˆ†åç”Ÿå‘½ç§‘å¦ã€€è¬›å¸«ï¼‰ é½Šè—¤ã€€æšï¼ˆå®®å´Žå¤§å¦ã€€è¾²å¦éƒ¨ç£åŒ»å¦ç§‘ã€€ç£åŒ»å¾®ç”Ÿç‰©å¦ç ”ç©¶å®¤ã€€å‡†æ•™æŽˆï¼‰ æ± ç”°ã€€è¼æ”¿ï¼ˆç†Šæœ¬å¤§å¦ãƒ’ãƒˆãƒ¬ãƒˆãƒã‚¦ã‚¤ãƒ«ã‚¹å¦å…±åŒç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€€å›½éš›å…ˆç«¯ç ”ç©¶éƒ¨é–€åˆ†åã‚¦ã‚¤ãƒ«ã‚¹ãƒ»éºä¼å¦åˆ†é‡Žåˆ†é‡Žã€€å‡†æ•™æŽˆï¼‰ ä¸Šé‡Žã€€è²´å°†ï¼ˆç†Šæœ¬å¤§å¦ãƒ’ãƒˆãƒ¬ãƒˆãƒã‚¦ã‚¤ãƒ«ã‚¹å¦å…±åŒç ”ç©¶ã‚»ãƒ³ã‚¿ãƒ¼ã€€æ„ŸæŸ“äºˆé˜²éƒ¨é–€æ„ŸæŸ“å…ç–«å¦åˆ†é‡Žã€€æ•™æŽˆï¼‰ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®ã‚¹ãƒ‘ã‚¤ã‚¯ã‚¿ãƒ³ãƒ‘ã‚¯è³ªï¼ˆæ³¨2ï¼‰ã®æ„ŸæŸ“
ss56235 2021/08/14
å…ç–«

ã‚¦ã‚¤ãƒ«ã‚¹

æ—¥æœ¬

COVID-19
ãƒªãƒ³ã‚¯
ç—‡çŠ¶ã€äºˆé˜²ã€çµŒéŽã¨æ²»ç™‚â€¦ã€€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã¨ã¯ï¼Ÿã€€ç¾æ™‚ç‚¹ã§åˆ†ã‹ã£ã¦ã„ã‚‹ã“ã¨ï¼ˆ2021å¹´5æœˆï¼‰ï¼ˆå¿½é‚£è³¢å¿—ï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
æµè¡Œã‹ã‚‰1å¹´ä»¥ä¸ŠãŒçµŒéŽã—ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ã«ã¤ã„ã¦æ§˜ã€…ãªã“ã¨ãŒåˆ†ã‹ã£ã¦ãã¾ã—ãŸã€‚ æµè¡ŒçŠ¶æ³ã€ç—‡çŠ¶ã€æ²»ç™‚ã€äºˆé˜²ãªã©ç¾æ™‚ç‚¹ã§åˆ†ã‹ã£ã¦ã„ã‚‹ã“ã¨ã«ã¤ã„ã¦ã¾ã¨ã‚ã¦ã„ã¾ã™ï¼ˆè¨˜äº‹ã®å†…å®¹ã¯2021å¹´5æœˆ29æ—¥æ™‚ç‚¹ã§ã®æƒ…å ±ã§ã™ï¼‰ã€‚ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¨ã¯ï¼Ÿæ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®æ§‹é€ ï¼ˆCDC Image Libraryã‚ˆã‚Šï¼‰ æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ï¼ˆSARSã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹2ï¼‰ã¯ã€æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡ï¼ˆCOVID-19ï¼‰ã®åŽŸå› ã‚¦ã‚¤ãƒ«ã‚¹ã§ã€RNAã‚¦ã‚¤ãƒ«ã‚¹ã§ã‚ã‚‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®ä»²é–“ã§ã™ã€‚ ã‚¦ã‚¤ãƒ«ã‚¹ç²’åã®è¡¨é¢ã«ã‚¹ãƒ‘ã‚¤ã‚¯è›‹ç™½ã¨å‘¼ã°ã‚Œã‚‹çªèµ·ãŒã‚ã‚Šã€ã“ã‚ŒãŒçŽ‹å† ã®ã‚ˆã†ã«è¦‹ãˆã‚‹ã“ã¨ã‹ã‚‰ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¨åä»˜ã‘ã‚‰ã‚Œã¾ã—ãŸã€‚ SARSã€MERSã€æ–°åž‹ã‚³ãƒãƒŠã®æ¯”è¼ƒï¼ˆç†è€…ä½œæˆï¼‰ ã“ã‚Œã¾ã§ã«ãƒ’ãƒˆã«æ„ŸæŸ“ã™ã‚‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¯4ç¨®é¡žçŸ¥ã‚‰ã‚Œã¦ãŠã‚Šã€ã‹ãœã®åŽŸå› ã®10ã€œ30ï¼…ã‚’å ã‚ã‚‹åŽŸå› ã‚¦ã‚¤ãƒ«ã‚¹ã¨ã—ã¦çŸ¥ã‚‰ã‚Œã¦ã„ã¾ã—ãŸã€‚ 2002å¹´ä¸å›½åºƒæ±çœã«ç«¯
ss56235 2021/05/30
COVID-19

ã‚³ãƒãƒŠ

ã‚¦ã‚¤ãƒ«ã‚¹

ã¾ã¨ã‚

ãƒ¯ã‚¯ãƒãƒ³
ãƒªãƒ³ã‚¯
ã‚¤ãƒ³ãƒ‰åž‹ã¨è‹±å›½åž‹ã®ãƒã‚¤ãƒ–ãƒªãƒƒãƒ‰å¤‰ç•°æ ªã€ãƒ™ãƒˆãƒŠãƒ ã§ç™ºè¦‹
ãƒ™ãƒˆãƒŠãƒ ã®ã‚°ã‚¨ãƒ³ãƒ»ã‚¿ã‚¤ãƒ³ãƒ»ãƒãƒ³ä¿å¥ç›¸ã¯ï¼’ï¼™æ—¥ã€ã‚¤ãƒ³ãƒ‰åž‹ã¨è‹±å›½åž‹ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹å¤‰ç•°æ ªãŒåˆã‚ã•ã£ãŸæ–°ãŸãªå¤‰ç•°æ ªã‚’ç™ºè¦‹ã—ãŸã¨æ˜Žã‚‰ã‹ã«ã—ãŸã€‚ãƒãƒŽã‚¤ã§ï¼‘æœˆæ’®å½±ï¼ˆï¼’ï¼ï¼’ï¼‘å¹´ã€€ãƒã‚¤ã‚¿ãƒ¼/KHAMï¼‰ ï¼»ãƒãƒŽã‚¤ã€€ï¼’ï¼™æ—¥ã€€ãƒã‚¤ã‚¿ãƒ¼ï¼½ - ãƒ™ãƒˆãƒŠãƒ ã®ã‚°ã‚¨ãƒ³ãƒ»ã‚¿ã‚¤ãƒ³ãƒ»ãƒãƒ³ä¿å¥ç›¸ã¯ï¼’ï¼™æ—¥ã€ã‚¤ãƒ³ãƒ‰åž‹ã¨è‹±å›½åž‹ã®æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹å¤‰ç•°æ ªãŒåˆã‚ã•ã£ãŸæ–°ãŸãªå¤‰ç•°æ ªã‚’ç™ºè¦‹ã—ãŸã¨æ˜Žã‚‰ã‹ã«ã—ãŸã€‚ã‚ªãƒ³ãƒ©ã‚¤ãƒ³ãƒ¡ãƒ‡ã‚£ã‚¢ã®ï¼¶ï¼®ã‚¨ã‚¯ã‚¹ãƒ—ãƒ¬ã‚¹ãŒä¼ãˆãŸã€‚ æ–°ç¨®ã®å¤‰ç•°æ ªã¯æ–°ãŸãªæ„ŸæŸ“è€…ã‹ã‚‰è¦‹ã¤ã‹ã£ãŸã¨ã—ã€ã€Œã‚¤ãƒ³ãƒ‰åž‹ã®å¤‰ç•°æ ªã«ã€ã‚‚ã¨ã‚‚ã¨è‹±å›½åž‹ã«å«ã¾ã‚Œã¦ã„ãŸå¤‰ç•°ãŒåŠ ã‚ã£ãŸã‚‚ã®ã ã€ã¨è¿°ã¹ãŸã€‚ã¾ãŸã€æ—¢å˜æ ªã‚ˆã‚Šã‚‚ã¯ã‚‹ã‹ã«æ„ŸæŸ“åŠ›ãŒå¼·ãã€è¤‡è£½ãŒéžå¸¸ã«é€Ÿã„ã“ã¨ã‚‚å®Ÿé¨“ã§åˆ†ã‹ã£ãŸã¨ã„ã†ã€‚
ss56235 2021/05/29
ã‚³ãƒãƒŠ

ã‚¦ã‚¤ãƒ«ã‚¹

COVID-19
ãƒªãƒ³ã‚¯
20ä»£ï½ž50ä»£ã®çš†ã•ã¾ã¸ï¼šä»Šã€å®Ÿè¡Œãƒ»æ‹¡æ•£ã—ã¦ã»ã—ã„ã“ã¨ï½œã‚³ãƒãƒŠå°‚é–€å®¶æœ‰å¿—ã®ä¼š | COVID-PAGE
å¤‰æ›´å±¥æ´ï¼šæ–‡è¨€å¤‰æ›´ã€Œã„ã¤ã‚‚ä¼šã£ã¦ã„ã‚‹äººã€â†’ã€ŒåŒå±…äººã€ï¼ˆ2021å¹´1æœˆ20æ—¥ 21:57ï¼‰ æœ‰å¿—ã®ä¼šã®å°¾èº«ã§ã™ã€‚ ã©ã†ã‹ã€ä»¥ä¸‹ã®ãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ã‚’ãŠçŸ¥ã‚Šåˆã„ã®æ–¹ã‚„ä»–ã®SNSç‰ã«ã‚‚æ‹¡æ•£ã—ã¦ã„ãŸã ã‘ã‚Œã°ã€æœ¬å½“ã«ã†ã‚Œã—ã„ã§ã™ã€‚ â—†â—‡â—†â—‡â—† çš†ã•ã‚“æ—¢ã«ã”æ‰¿çŸ¥ã®ã‚ˆã†ã«ã€ç¾åœ¨ã€ç·Šæ€¥äº‹æ…‹å®£è¨€ãŒç™ºå‡ºã•ã‚Œã¦ãŠã‚Šã€æ—¥æœ¬ã®åŒ»ç™‚ã¨çµŒæ¸ˆã¯æ·±ããƒ€ãƒ¡ãƒ¼ã‚¸ã‚’å—ã‘ã¤ã¤ã‚ã‚Šã¾ã™ã€‚ã™ã§ã«ã€å¤±æ¥çŽ‡ã¯é«˜ããªã£ã¦ã„ã¾ã™ãŒã€æ„ŸæŸ“æ‹¡å¤§ãŒåŽã¾ã‚‰ãªã„ã¨ã€ã•ã‚‰ã«å½±éŸ¿ãŒåºƒãŒã‚Šã¾ã™ã€‚ã¾ãŸã€åŒ»ç™‚ã§ã¯ã€ä¾‹ãˆã°éª¨æŠ˜ã‚„ç›²è…¸ï¼ˆè™«åž‚ç‚Žï¼‰ã«ãªã£ã¦ã‚‚è¨ºå¯Ÿã—ã¦ã‚‚ã‚‰ãˆãªã„ã¨ã„ã£ãŸçŠ¶æ³ã«ãªã£ã¦ã„ã¾ã™ã€‚ ç¾åœ¨ã®ã‚ˆã†ã«å¸‚ä¸ã§ã®æ„ŸæŸ“ãŒåºƒãŒã‚‹ã¨ã€æ„ŸæŸ“äºˆé˜²ç–ã‚’ä¸€äººã²ã¨ã‚ŠãŒå®Ÿè¡Œã—ã¦ã„ã‚‹ã ã‘ã§ã¯ã€æ„ŸæŸ“ã®æ‹¡å¤§ã‚’åŽã‚ã‚‹ã“ã¨ã¯é›£ã—ã„ã§ã™ã€‚æ¬¡ã®å¤§ããªæµè¡ŒãŒèµ·ããªã„ãƒ¬ãƒ™ãƒ«ã¾ã§æ„ŸæŸ“çŠ¶æ³ã‚’ä¸‹ã’ã¦ãŠããŸã‚ã«ã‚‚ã€ã§ãã‚‹ã ã‘ã€Œäººã¨äººã¨ã®æŽ¥è§¦æ©Ÿä¼šã‚’æ¸›ã‚‰ã™ã€ã¨ã„ã†ã€ ç¤¾ä¼šå…¨ä½“ã§ã®å–ã‚Šçµ„ã¿ãŒå¿…è¦ãªçŠ¶æ³ã«ã‚ã‚Šã¾ã™ã€‚
ss56235 2021/01/21
COVID-19

ã‚¦ã‚¤ãƒ«ã‚¹
ãƒªãƒ³ã‚¯
COVID-19æ²»ç™‚ã®ä»Šå¾Œã®æ–¹å‘æ€§ã‚’è‚ç‚Žã‚¦ã‚¤ãƒ«ã‚¹ç ”ç©¶è€…ãŒè€ƒãˆã‚‹ï½œTada
ã¯ã˜ã‚ã«åƒ•ã¯åŒ»è€…ã«ãªã£ã¦ã‹ã‚‰ãšã£ã¨è‡¨åºŠã‚’ã—ãªãŒã‚‰è‚ç‚Žã‚¦ã‚¤ãƒ«ã‚¹æ²»ç™‚ã®é€²æ©ã‚’çœŸæ¨ªã§è¦‹ã¦ããŸã—ã€ç ”ç©¶è€…ã«ãªã£ã¦ã‹ã‚‰ã¯å®¿ä¸»å…ç–«ãƒ»æ²»ç™‚ç’°å¢ƒã«é©å¿œã—ãŸã‚¦ã‚¤ãƒ«ã‚¹ã‚²ãƒŽãƒ å¤‰ç•°ã‚’å°‚é–€ã«ã—ã¦ããŸã®ã§ã€ãã®è¦³ç‚¹ã‹ã‚‰å°‘ã—ã€ä»Šå¾Œã®COVID-19è¨ºç™‚ã¯ã©ã®ã‚ˆã†ã«ãªã£ã¦ã„ãã®ã‹ã«ã¤ã„ã¦åƒè¶ŠãªãŒã‚‰æ›¸ã‹ã›ã¦ã‚‚ã‚‰ã†ã€‚ çµè«–ã‹ã‚‰è¨€ã†ã¨ã€ç¾åœ¨ä¸–ç•Œä¸ã®ç ”ç©¶è€…ãŒã“ã®å•é¡Œã«å–ã‚Šçµ„ã‚“ã§ãŠã‚Šï¼ˆã‚ã‚Œã‚ã‚Œã®ç ”ç©¶ã‚°ãƒ«ãƒ¼ãƒ—ã‚‚ç„¶ã‚Šï¼‰ã€æ¤œæŸ»ãƒ»æ²»ç™‚ã«é–¢ã—ã¦ã¯ã„ãšã‚Œã‚‚æ€¥é€Ÿãªå‹¢ã„ã§é€²æ©ã—èªå¯ã•ã‚Œã¦ã„ãã§ã‚ã‚ã†ã—ã€å®Ÿè‡¨åºŠã‹ã‚‰é‡ç—‡åŒ–ã«é–¢ã‚ã‚‹å› åãŒæŠ½å‡ºã•ã‚Œã€é‡ç—‡åŒ–äºˆæ¸¬ã®ãŸã‚ã®é©åˆ‡ãªãƒ•ãƒãƒ¼ãƒãƒ£ãƒ¼ãƒˆãŒä½œæˆã•ã‚Œã‚‹ã§ã‚ã‚ã†ã—ã€æ„ŸæŸ“è€…ã¯æœ€å¤§é™æ—©æœŸã®ã†ã¡ã«æ¤œæŸ»ãƒ»è¨ºæ–ã•ã‚Œã‚‹åŠªåŠ›ã‚’ã—ã€ãã®æ²»ç™‚æŒ‡é‡ã«ã‚ˆã£ã¦çµŒéŽè¦³å¯Ÿã‹æ²»ç™‚é©å¿œã‹ã‚’åˆ¤æ–ã™ã‚‹å½¢ã«ãªã‚‹ã¨æ€ã†ï¼ˆå¤šãã®ã‚¦ã‚¤ãƒ«ã‚¹æ²»ç™‚ãŒãã†ã§ã‚ã‚‹ã‚ˆã†ã«ï¼‰ã€‚ã“ã‚Œã¾ã§Båž‹è‚ç‚Žï¼ˆHBVï¼‰ã€Cåž‹è‚ç‚Žï¼ˆHCVï¼‰æ‚£è€…æ•°ç™¾äººä»¥ä¸Šã®æ²»ç™‚ã‚’ã—ã¦ããŸåŒ»è€…ã¨ã—ã¦ã®çµŒ
ss56235 2020/05/11
ã‚¦ã‚¤ãƒ«ã‚¹

ç ”ç©¶

æ¤œæŸ»

COVID-19

åŒ»ç™‚
ãƒªãƒ³ã‚¯
æ–°åž‹ã‚³ãƒãƒŠã€Œæ¬§å·žæ ªã€ã®æ„ŸæŸ“åŠ›ã€Œæ¦æ¼¢æ ªã€ã‚ˆã‚Šå¼·ã„ã€€çªèµ·éƒ¨ã«14ã®å¤‰ç•°ï¼ˆæœ¨æ‘æ£äººï¼‰ - ã‚¨ã‚ã‚¹ãƒ‘ãƒ¼ãƒˆ - Yahoo!ãƒ‹ãƒ¥ãƒ¼ã‚¹
ã€Œæ¬§å·žæ ªã®åˆ†å¸ƒã¯é©šãã¹ãé€Ÿã•ã§å¢—ã™ã€ï¼»ãƒãƒ³ãƒ‰ãƒ³ç™ºï¼½æ–°åž‹ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã®å¤‰ç•°ã«ã¤ã„ã¦ç±³ãƒã‚¹ã‚¢ãƒ©ãƒ¢ã‚¹å›½ç«‹ç ”ç©¶æ‰€ã¯4æœˆ29æ—¥ã€ã‚¹ãƒ‘ã‚¤ã‚¯ã‚¿ãƒ³ãƒ‘ã‚¯è³ªã«ãŠã‘ã‚‹14ã®å¤‰ç•°ã‚’ç‰¹å®šã—ã€ãã®ä¸ã®1ã¤ã®å¤‰ç•°æ ªï¼ˆD614Gã€ã„ã‚ã‚†ã‚‹æ¬§å·žæ ªï¼‰ãŒ2æœˆåˆã‚ã‹ã‚‰æ¬§å·žã§æ„ŸæŸ“æ‹¡å¤§ã—ã€ä¸–ç•Œä¸ã«åºƒãŒã£ãŸã¨æŒ‡æ‘˜ã™ã‚‹æŸ»èªå‰è«–æ–‡ã‚’ç™ºè¡¨ã—ã¾ã—ãŸã€‚ è«–æ–‡ã¯ã€ŒD614Gã®åˆ†å¸ƒã¯é©šãã¹ãé€Ÿã•ã§å¢—ã—ã¦ãŠã‚Šã€ã‚‚ã¨ã®æ¦æ¼¢æ ªã¨æ¯”è¼ƒã—ã¦ã‚ˆã‚Šè¿…é€Ÿã«æ‹¡æ•£ã§ãã‚‹é©å¿œåº¦ã®å„ªä½æ€§ã‚’ç¤ºã—ã¦ã„ã‚‹ã€ã¨åˆ†æžã—ã¦ã„ã¾ã™ã€‚ç†é è‘—è€…ã®ãƒ™ãƒ†ã‚£ãƒ»ã‚³ãƒ¼ãƒãƒ¼æ°ã¯ãƒ•ã‚§ã‚¤ã‚¹ãƒ–ãƒƒã‚¯ã«ã“ã†æ›¸ã„ã¦ã„ã¾ã™ã€‚ ã€Œæ–°èˆˆã‚¦ã‚¤ãƒ«ã‚¹ãŒéžå¸¸ã«é€ŸãåºƒãŒã‚Šã€3æœˆã«ã¯ãƒ‘ãƒ³ãƒ‡ãƒŸãƒƒã‚¯ã®æ”¯é…çš„ãªæ ªã«ãªã£ãŸã“ã¨ã‚’è¦‹ã‚‹ã¨å¿ƒé…ã ã€‚ã“ã®å¤‰ç•°æ ªãŒæµè¡Œã—å§‹ã‚ã‚‹ã¨ã€ãã‚Œã¾ã§ã«ãã®åœ°åŸŸã§åºƒãŒã£ã¦ã„ãŸæ ªã«å–ã£ã¦ä»£ã‚ã‚‹ã€‚D614Gã®æ„ŸæŸ“åŠ›ã¯å¼·ã„ã€ ã‚³ãƒãƒŠã‚¦ã‚¤ãƒ«ã‚¹ã¯è¡¨é¢ã«ä»–ã®ã‚¦ã‚¤ãƒ«ã‚¹ã¨ã¯ç•°ãªã‚‹ã€ŒçŽ‹å† ï¼ˆã‚³ãƒãƒŠï¼‰ã€ã®ã‚ˆã†ãªçªèµ·ï¼ˆã‚¹ãƒ‘ã‚¤ã‚¯ï¼‰ã‚’æŒã£
ss56235 2020/05/09
COVID-19

ã‚¦ã‚¤ãƒ«ã‚¹
ãƒªãƒ³ã‚¯
1